期刊文献+

慢性房颤患者左右心房胶原和基质金属蛋白酶表达差异 被引量:2

Differential expression of collagen and matrix metalloproteinases between left and right atria in patients with chronic atrial fibrillation
原文传递
导出
摘要 本文旨在研究慢性房颤患者左右心房胶原、基质金属蛋白酶(matrix metalloproteinases,MMPs)、基质金属蛋白酶抑制剂(tissue inhibitors of metalloproteinases,TIMPs)的mRNA水平是否存在差异。选择接受开胸换心脏瓣膜的手术病人共45例,其中慢性房颤患者27例,窦性心律患者18例;术中分别取左、右心耳组织,采用半定量RT-PCR法测定I型胶原、III型胶原、基质金属蛋白酶-1,9(MMP1、MMP9)以及基质金属蛋白酶抑制剂-1(TMP1)的mRNA表达水平。结果显示:(1)与窦性心律组相比,慢性房颤组患者左、右心房肌组织中I型胶原、MMP1、MMP9的mRNA表达水平均上调(P<0.05),TMP1的表达水平均下调(P<0.01);(2)窦性心律组患者左、右心房肌组之间I型胶原、III型胶原、MMP1、MMP9、TMP1的mRNA表达水平的差异均无统计学显著意义(P>0.05);(3)慢性房颤组患者MMP1的mRNA在右心房肌组织中表达水平较左心房高(P<0.05),MMP9的mRNA在左心房肌组织中表达水平较右心房高(P<0.01);(4)无论左心房还是右心房,MMP1、MMP9的mRNA表达水平均与I型胶原的mRNA表达水平呈正相关,与TMP1的mRNA表达水平呈负相关。以上结果表明,心房肌组织中MMP1/TMP1以及MMP9/TMP1的mRNA表达水平失衡引起I型胶原转录水平的改变,可能是慢性房颤患者心房肌间质纤维化的分子基础,在慢性房颤的过程中,MMPs的mRNA在左、右心房的表达是有差异的。 The present study aimed to investigate the mRNA expression levels of collagen, matrix metalloproteinases (MMPs), and tissue inhibitors of metalloproteinases (TIMPs) in the left and right atria in patients with chronic atrial fibrillation (CAF). Forty five patients with valvular heart disease were sampled in this study, including 18 patients with sinus rhythm (SR), 27 patients with CAF.Clinical data of these patients were collected, and the left and right atrial appendages were obtained from these patients during heart valvular replacement surgery. The mRNA levels of collagen type I, collagen type III, MMP1, MMP9, TMP1 of the atria were then measured by semi-quantitative RT-PCR. The results obtained were as follows. Compared to those in SR group, in atria of CAF group,the mRNA levels of collagen type I, MMP1 and MMP9 increased (P〈0.05), while the mRNA level of TMP1 decreased (P〈0.01). There were no significant differences in the mRNA levels of collagen type I, collagen type III, MMP1, MMP9 and TMP1 between the left and right atria of SR group (P〉0.05). In CAF group, the mRNA level of MMP1 in the right atrium was higher than that in the left atrium (P〈0.05), however, the mRNA level of MMP9 in the left atrium was higher than that in the right atrium (P〈0.01). In both the left and right atria, the mRNA of collagen type I was positively correlated with the corresponding atrial diameter; the mRNA of MMP1 and MMP9 was positively correlated with the mRNA of collagen type I, and was negatively correlated with the mRNA of TMP1.These results suggest that the increased level of collagen type I associated with selective upregulation of MMP 1, 9 and downregulation of TMP1, 9 in the atrium might be the molecular basis of atrial interstitial fibrosis in patients with CAF. Moreover, during CAF development, there is difference in the expression of MMPs between the left and right atria.
出处 《生理学报》 CAS CSCD 北大核心 2009年第3期211-216,共6页 Acta Physiologica Sinica
关键词 心房颤动 胶原 基质金属蛋白酶 基质金属蛋白酶抑制剂 atrial fibrillation collagen matrix metalloproteinases tissue inhibitors of metalloproteinases
  • 相关文献

参考文献11

二级参考文献32

  • 1黄兵,陈雷,吴学仁,孙立忠,董超,刘振伟,李立环.慢性房颤患者右心房细胞电压依赖性钾电流变化的研究[J].中国病理生理杂志,2005,21(1):77-80. 被引量:9
  • 2柯丹,许春萱,张建成,陈林,林亚洲,林立芳,胡锡衷.心房颤动患者心房组织中明胶酶的基因表达及活性变化[J].中华心血管病杂志,2005,33(2):137-142. 被引量:26
  • 3Spinale FG, Coker ML, Bond BR, et al. Myocardial matrix degradation and metalloproteinase activation in the failing heart : a potential therapeutic target. Cardilvasc Res, 2000, 46:225-238.
  • 4Saharinen J, Hyytiainen M, Taipale J, et al. Latent transforming growth factor-beta binding proteins ( LTBPs ) structural extracellular nmtrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev, 1999, 10 : 99-117.
  • 5Peterson JT, Li H, Dillon L, et al. Evolution of matrix metalloproteinase and tissue inhibitor expression during heart failure progression int infracted rat. Cardiovasc Res, 2000, 46:307-315.
  • 6Nagahiro N, Kazuhiro Y, Yasushi S, et al. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc Res, 2003, 57:766-774.
  • 7Ducharme A , Frantz S, Aikawa M, et al. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest, 2000, 106:55-62.
  • 8Heymans S, Luttun A, Nuyens D, et al. Inhibition of plasminogen activators or matrix metallproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure . Nat Med, 1999, 5:1135-1142.
  • 9Borg TK, Burgess ML. Holding it all together: organization and function(s) of the extracellular matrix of the heart. Heart Failure,1993,8 : 230-238.
  • 10Li YY, Feldman AM, Sun Y, et al. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart.Circulation, 1998, 98 : 1728-1734.

共引文献56

同被引文献33

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部